No profile data available.
Brooks Laboratories Limited (BROOKS.NS) is a healthcare company in the drug manufacturing contractors industry, based in Mumbai, India, with about 347 full-time employees.
It reported revenue of 821.86 million INR for fiscal year 2025, up 4.0% from fiscal year 2024, and net income of -99.67 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 165.66 million INR, down 56.9% from a year before. Its market capitalization was 2.07 billion INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
Brooks Laboratories Limited operates as a pharmaceutical manufacturer in India and internationally. It operates in two segments, Manufacturing and Trading.
Brooks Laboratories reported 821.86 million INR in revenue for fiscal year 2025, up 4.0% from 790.12 million INR in fiscal year 2024. In Q3 2026 revenue was 165.66 million INR.
2.07 billion INR as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Lyka Labs Limited (LYKALABS.NS), Everest Organics Limited (EVERESTO.BO), Gennex Laboratories Limited (GENNEX.BO), Coral Laboratories Limited (CORALAB.BO).